Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 41 (7), 613-621

Maturation of Cardiomyocytes Derived From Human Pluripotent Stem Cells: Current Strategies and Limitations

Affiliations
Review

Maturation of Cardiomyocytes Derived From Human Pluripotent Stem Cells: Current Strategies and Limitations

Yanqing Jiang et al. Mol Cells.

Abstract

The capacity of differentiation of human pluripotent stem cells (hPSCs), which include both embryonic stem cells and induced pluripotent stem cells, into cardiomyocytes (CMs) in vitro provides an unlimited resource for human CMs for a wide range of applications such as cell based cardiac repair, cardiac drug toxicology screening, and human cardiac disease modeling. However, their applicability is significantly limited by immature phenotypes. It has been well known that currently available CMs derived from hPSCs (hPSC-CMs) represent immature embryonic or fetal stage CMs and are functionally and structurally different from mature human CMs. To overcome this critical issue, several new approaches aiming to generate more mature hPSC-CMs have been developed. This review describes recent approaches to generate more mature hPSC-CMs including their scientific principles, advantages, and limitations.

Keywords: cardiomyocytes; human pluripotent stem cells; immaturity; maturation.

Figures

Fig. 1
Fig. 1
Currently available strategies for maturing cardiomyocytes derived from human pluripotent stem cells.

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

References

    1. Amin A.S., Tan H.L., Wilde A.A. Cardiac ion channels in health and disease. Heart Rhythm . 2010;7:117–126. - PubMed
    1. Camci-Unal G., Annabi N., Dokmeci M.R., Liao R., Khademhosseini A. Hydrogels for cardiac tissue engineering. NPG Asia Mater . 2014;6:e99.
    1. Chattergoon N.N., Giraud G.D., Louey S., Stork P., Fowden A.L., Thornburg K.L. Thyroid hormone drives fetal cardiomyocyte maturation. FASEB J . 2012;26:397–408. - PMC - PubMed
    1. Davis R.P., Casini S., van den Berg C.W., Hoekstra M., Remme C.A., Dambrot C., Salvatori D., Oostwaard D.W., Wilde A.A., Bezzina C.R., et al. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation . 2012;125:3079–3091. - PubMed
    1. DeForest C.A., Anseth K.S. Advances in bioactive hydrogels to probe and direct cell fate. Annu Rev Chem Biomol Eng . 2012;3:421–444. - PubMed
Feedback